Chronic Heart Failure
Across
- 4. – Dietary restriction in CHF to control fluid retention
- 9. – A mineralocorticoid receptor antagonist (MRA)
- 10. – A classic symptom of CHF (shortness of breath when lying flat)
- 14. – A soluble guanylate cyclase stimulator for CHF
- 16. – An SGLT2 inhibitor used for CHF treatment
- 17. – A common symptom of CHF due to low cardiac output
- 20. – ACE inhibitor used for CHF management
- 21. – A non-selective beta blocker used in CHF
- 22. – Used in CHF, especially in African American patients
- 23. – Another ACE inhibitor used for CHF treatment
- 24. – Often combined with Hydralazine in CHF
Down
- 1. – An ARB used in CHF when ACE inhibitors are not tolerated
- 2. – Combined with Valsartan in ARNi therapy
- 3. – Fluid retention in CHF patients
- 5. – The gold standard for CHF diagnosis
- 6. – Beta blocker that improves CHF survival
- 7. – Another SGLT2 inhibitor for CHF
- 8. – A potent loop diuretic alternative
- 11. – A beta-1 selective beta blocker used in CHF
- 12. – A positive inotrope used to reduce CHF hospitalizations
- 13. – Biomarker elevated in CHF diagnosis
- 15. – Slows heart rate by inhibiting the SA node
- 18. – An alternative MRA to Spironolactone
- 19. – A loop diuretic for managing congestion in CHF